Zagreb, Croatia

Slobodan Djokic

This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehranbena I Kozmeticka Industrija. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Slobodan Djokic. Retrieved from https://idiyas.com/inventor/slobodan-djokic-w73prsv9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Slobodan Djokic: Innovator in Macrolide Antibiotics

Introduction

Slobodan Djokic is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibiotics. His work has implications for medical treatments and showcases the importance of innovation in healthcare.

Latest Patents

Djokic holds a patent for "9-deoxo-9a-aza-11-deoxy-9a-homoerythromycin A 9a,11-cyclic carbamates." This invention relates to novel semisynthetic macrolide antibiotics from the genus of azalides. The formula of the invention is represented as (I) ##STR1##, highlighting its unique chemical structure and potential applications in medicine.

Career Highlights

He is currently employed at Pliva, a prominent pharmaceutical, chemical, food, and cosmetic industry company. His role at Pliva has allowed him to focus on research and development, contributing to advancements in antibiotic therapies.

Collaborations

Throughout his career, Djokic has collaborated with talented colleagues, including Gabrijela Kobrehel and Gorjana Lazarevski. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Slobodan Djokic's work in the field of macrolide antibiotics exemplifies the impact of innovative thinking in pharmaceuticals. His contributions are vital for the ongoing development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…